Endovascular versus Surgical Lower Extremity Revascularization among Patients with Chronic Kidney Disease
Table 2
Median follow-up (in person-years (PY) and incidence of the specified outcomes of interest).
Endovascular
Surgical
Adjusted HR (95% CI)
Follow-up, median PY
Events, N(%)
Incidence (per 100 PY)
Follow-up, median PY
Events, N(%)
Incidence (per 100 PY)
Major adverse limb events (MALE)
0.7
23,135 (39%)
30.1
0.8
2476 (27%)
18.7
1.52 (1.46–1.59)
Repeat revascularization
0.7
20,917 (35%)
26.3
0.9
2102 (23%)
15.2
1.65 (1.57–1.72)
Amputation
1.5
2896 (5%)
2.5
1.3
486 (5%)
2.9
0.81 (0.73–0.89)
Death
1.4
24,075 (40%)
21.5
1.3
4128 (44%)
24.9
0.85 (0.82–0.88)
Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) include the inverse probability of treatment weights and compare patients with chronic kidney disease undergoing an initial endovascular versus surgical revascularization.